Sotrovimab Expanded Access Treatment Protocol (COVID-19) - Trial NCT05235347
Access comprehensive clinical trial information for NCT05235347 through Pure Global AI's free database. This phase not specified trial is sponsored by Vir Biotechnology, Inc. and is currently No longer available. The study focuses on Covid19.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Vir Biotechnology, Inc.
Timeline & Enrollment
N/A
N/A
N/A
Summary
An expanded access program for sotrovimab administered intravenously to participants with
 COVID-19 illness who meet current authorized/approved criteria for use of sotrovimab.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05235347
Non-Device Trial